WO2003052412A3 - Diagnosis of inflammatory bowel disease - Google Patents

Diagnosis of inflammatory bowel disease Download PDF

Info

Publication number
WO2003052412A3
WO2003052412A3 PCT/GB2002/005719 GB0205719W WO03052412A3 WO 2003052412 A3 WO2003052412 A3 WO 2003052412A3 GB 0205719 W GB0205719 W GB 0205719W WO 03052412 A3 WO03052412 A3 WO 03052412A3
Authority
WO
WIPO (PCT)
Prior art keywords
inflammatory bowel
bowel disease
diagnosis
ibdbp1
individual
Prior art date
Application number
PCT/GB2002/005719
Other languages
French (fr)
Other versions
WO2003052412A2 (en
Inventor
Maxine Johanna Allen
John Matthew Herbert
Heel David Van
Original Assignee
Oxagen Ltd
Maxine Johanna Allen
John Matthew Herbert
Heel David Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxagen Ltd, Maxine Johanna Allen, John Matthew Herbert, Heel David Van filed Critical Oxagen Ltd
Priority to AU2002350975A priority Critical patent/AU2002350975A1/en
Publication of WO2003052412A2 publication Critical patent/WO2003052412A2/en
Publication of WO2003052412A3 publication Critical patent/WO2003052412A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A novel gene associated with inflammatory bowel disease, termed IBDBP1 and a method of diagnosing inflammatory bowel disease or determining susceptibility to inflammatory bowel disease in an individual, which method comprises typing the IBDBP1 gene region or the IBDBP1 protein of the individual, thereby determining whether the individual has, or is susceptible to inflammatory bowel disease.
PCT/GB2002/005719 2001-12-17 2002-12-17 Diagnosis of inflammatory bowel disease WO2003052412A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002350975A AU2002350975A1 (en) 2001-12-17 2002-12-17 Diagnosis of inflammatory bowel disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130116.7A GB0130116D0 (en) 2001-12-17 2001-12-17 Gene linkage
GB0130116.7 2001-12-17

Publications (2)

Publication Number Publication Date
WO2003052412A2 WO2003052412A2 (en) 2003-06-26
WO2003052412A3 true WO2003052412A3 (en) 2004-02-26

Family

ID=9927755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/005719 WO2003052412A2 (en) 2001-12-17 2002-12-17 Diagnosis of inflammatory bowel disease

Country Status (3)

Country Link
AU (1) AU2002350975A1 (en)
GB (1) GB0130116D0 (en)
WO (1) WO2003052412A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023255A1 (en) * 1997-10-31 1999-05-14 Cedars-Sinai Medical Center Methods of identifying and diagnosing inflammatory bowel disease or subtypes with the nramp locus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023255A1 (en) * 1997-10-31 1999-05-14 Cedars-Sinai Medical Center Methods of identifying and diagnosing inflammatory bowel disease or subtypes with the nramp locus

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AHMAD T ET AL: "Review article: The genetics of inflammatory bowel disease", ALIMENTARY PHARMACOLOGY AND THERAPEUTICS, vol. 15, no. 6, June 2001 (2001-06-01), pages 731 - 748, XP002260830, ISSN: 0269-2813 *
DATABASE EMBL [online] 1 October 2002 (2002-10-01), OTTENWAELDER ET AL., XP002260835, retrieved from EMBL Database accession no. Q8N394 *
DATABASE EMBL [online] 12 March 2001 (2001-03-12), MUZNY ET AL., XP002260834, retrieved from EMBL Database accession no. AC090667 *
DATABASE EMBL [online] 14 December 2001 (2001-12-14), LEACH ET AL., XP002260832, retrieved from EMBL Database accession no. AX309874 *
DATABASE EMBL [online] 21 September 2002 (2002-09-21), OTA ET AL., XP002260833, retrieved from EMBL Database accession no. BD127696 *
DECHAIRO BRYAN ET AL: "Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)", EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 9, no. 8, August 2001 (2001-08-01), pages 627 - 633, XP002260831, ISSN: 1018-4813 *
RUDOLPH M W ET AL: "A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 51, no. 3, May 2001 (2001-05-01), pages 183 - 190, XP004239477, ISSN: 0939-6411 *
TAYLOR K D ET AL: "MINIREVIEW INFLAMMATORY BOWEL DIESEASE II. GENE MAPPING", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 74, no. 1/2, September 2001 (2001-09-01), pages 22 - 44, XP001089825, ISSN: 1096-7192 *

Also Published As

Publication number Publication date
GB0130116D0 (en) 2002-02-06
AU2002350975A1 (en) 2003-06-30
WO2003052412A2 (en) 2003-06-26
AU2002350975A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
WO2005114190A3 (en) Methods of identifying biomarkers
WO2004020968A3 (en) Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
EP2357478A3 (en) Diagnosis of disease
PL1625403T3 (en) Method for the prediction, diagnosis and differential diagnosis of alzheimer s disease
WO2000066067A3 (en) Ibd-associated microbial antigens and methods of using same
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
WO2000072015A3 (en) Diagnostics and therapeutics for cardiovascular disorders
FR2703693B1 (en) Rapid method of determining a DNA sequence and application to sequencing and diagnosis.
AU3878697A (en) Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
WO2004028341A3 (en) Susceptibility gene for human stroke; methods of treatment
WO2003027309A3 (en) Diagnostic probe detection system
WO2004043232A3 (en) Methods for identifying risk of melanoma and treatments thereof
WO2006046270A3 (en) Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
MXPA01005698A (en) Assay for anti transglutaminase antibodies detection useful in celiac disease diagnosis.
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
WO2003052412A3 (en) Diagnosis of inflammatory bowel disease
WO1999058639A3 (en) Structural proteins of fish pancreatic disease virus and uses thereof
WO2005019471A3 (en) Periostin-like factor: compositions and methods for making and using the same
WO2002033046A3 (en) Glucose transport-related genes and uses thereof
WO2003018842A1 (en) Novel gene nedl-1
WO2001077380A3 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene
WO2002010138A3 (en) Uses of mammalian genes and related reagents
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
WO2004083232A3 (en) Receptor proteins
WO2001029255A3 (en) Diagnostic test for cephalic pain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP